Home / Dantrolene / Canada
CA ATC M03CA01 · updated 2 Nov 2026
Dantrolene shortage in Canada
Is there a Dantrolene shortage in Canada?
Yes. As of 2 Nov 2026, 3 Dantrolene products are reported short in Canada, the first since 20 Apr 2026. The company estimate for the return is 20 Nov 2026 (latest 31 Jan 2027). Main reason: manufacturing problem.
Also short in Italy, Australia. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | DANTRIUM INTRAVENOUS (6x 20mg vials) | KNIGHT THERAPEUTICS INC. | 20 Apr 2026 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | DANTROLENE SODIUM FOR INJECTION, USP (20MG) | HIKMA CANADA LIMITED | 27 Aug 2026 | 31 Jan 2027 | Increased demand Demand increase for the drug |
| CA | DANTRIUM CAPSULES (100 Capsules) | KNIGHT THERAPEUTICS INC. | 27 Oct 2026 | 20 Nov 2026 | Manufacturing problem Disruption of the manufacture of the drug |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.